AVT29 (aflibercept high dose biosimilar)
/ Alvotech, Advanz Pharma, Servier, Teva
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 12, 2026
AVT29-GL-C01: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema
(clinicaltrialsregister.eu)
- P2/3 | N=102 | Not yet recruiting | Sponsor: Alvotech Swiss AG
New P2/3 trial • Diabetic Macular Edema • Ophthalmology
March 09, 2026
AVT29-GL-C01: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants with Diabetic Macular Edema
(clinicaltrialsregister.eu)
- P2/3 | N=11 | Not yet recruiting | Sponsor: Alvotech Swiss AG
New P2/3 trial • Diabetic Macular Edema • Ophthalmology
1 to 2
Of
2
Go to page
1